Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?

1. Torres, P.
2. Cañete, F.
3. Núñez, L.
4. Aguilar, A.
5. Mesonero, F.
6. Calafat, M.
7. Fernández, C.
8. Teniente, A.
9. Mañosa, M.
10. López-Sanromán, A.
11. Domènech, E.